These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 36928846)

  • 1. The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders.
    Teal LB; Ingram SM; Bubser M; McClure E; Jones CK
    Adv Neurobiol; 2023; 30():37-99. PubMed ID: 36928846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models of human disease: challenges in enabling translation.
    McGonigle P; Ruggeri B
    Biochem Pharmacol; 2014 Jan; 87(1):162-71. PubMed ID: 23954708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology.
    Tricklebank MD; Robbins TW; Simmons C; Wong EHF
    Psychopharmacology (Berl); 2021 Jun; 238(6):1417-1436. PubMed ID: 33694032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective.
    Wong EH; Yocca F; Smith MA; Lee CM
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1269-84. PubMed ID: 20716397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of CNS disorders.
    McGonigle P
    Biochem Pharmacol; 2014 Jan; 87(1):140-9. PubMed ID: 23811310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.
    Millan MJ; Goodwin GM; Meyer-Lindenberg A; Ove Ögren S
    Eur Neuropsychopharmacol; 2015 May; 25(5):599-656. PubMed ID: 25836356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug discovery in psychiatric illness: mining for gold.
    Elmer GI; Kafkafi N
    Schizophr Bull; 2009 Mar; 35(2):287-92. PubMed ID: 19297381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing the Utility of Preclinical Research in Neuropsychiatry Drug Development.
    Kaffman A; White JD; Wei L; Johnson FK; Krystal JH
    Methods Mol Biol; 2019; 2011():3-22. PubMed ID: 31273690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative pharmacology in a quantitative world: diminishing value in the drug discovery process.
    Williams M
    Curr Opin Pharmacol; 2011 Oct; 11(5):496-500. PubMed ID: 21531622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Difficult Path to the Discovery of Novel Treatments in Psychiatric Disorders.
    Gribkoff VK; Kaczmarek LK
    Adv Neurobiol; 2023; 30():255-285. PubMed ID: 36928854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound optimization in early- and late-phase drug discovery: acceptable pharmacokinetic properties utilizing combined physicochemical, in vitro and in vivo screens.
    Caldwell GW
    Curr Opin Drug Discov Devel; 2000 Jan; 3(1):30-41. PubMed ID: 19649835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches in psychiatric drug development.
    van der Doef TF; Zaragoza Domingo S; Jacobs GE; Drevets WC; Marston HM; Nathan PJ; Tome MB; Tamminga CA; van Gerven JMA; Kas MJH
    Eur Neuropsychopharmacol; 2018 Sep; 28(9):983-993. PubMed ID: 30056086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNS Target Identification and Validation: Avoiding the Valley of Death or Naive Optimism?
    Hutson PH; Clark JA; Cross AJ
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():171-187. PubMed ID: 27575715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational research in psychiatry: The Research Domain Criteria Project (RDoC).
    Vilar A; Pérez-Sola V; Blasco MJ; Pérez-Gallo E; Ballester Coma L; Batlle Vila S; Alonso J; Serrano-Blanco A; Forero CG
    Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(3):187-195. PubMed ID: 29941228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future viable models of psychiatry drug discovery in pharma.
    Rizzo SJ; Edgerton JR; Hughes ZA; Brandon NJ
    J Biomol Screen; 2013 Jun; 18(5):509-21. PubMed ID: 23392517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter to the Editor: EDUCATIONAL ACTIVITIES RELATED TO THE ICD-11 CHAPTER ON MENTAL DISORDERS.
    Giallonardo V
    Turk Psikiyatri Derg; 2021; 32(4):291-292. PubMed ID: 34964105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of in vivo animal models to characterize the pharmacokinetic and pharmacodynamic properties of drug candidates in discovery settings.
    Amore BM; Gibbs JP; Emery MG
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):207-18. PubMed ID: 20053166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of transgenic systems in pharmaceutical research.
    Snaith MR; Törnell J
    Brief Funct Genomic Proteomic; 2002 Jul; 1(2):119-30. PubMed ID: 15239898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.